AkzoNobel posted Q1 2026 adjusted EBITDA €345 million, beating consensus €323 million, with margin expanding to 14.5% from 13.7%.
Reported revenue fell 9% YoY, driven by a 5% currency head‑wind and a 3% loss from the India business divestment; organic sales slipped 1%.
CEO Greg Poux‑Guillaume said price hikes and cost cuts offset Middle East supply‑cost pressures and reaffirmed full‑year 2026 EBITDA guidance of ≥ €1.47 billion.
The company targets over 16% adjusted EBITDA margin and 16‑19% return on investment over the medium term.